Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
Galectin Therapeutics (NASDAQ:GALT) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.17) per share. This is a 54.55 percent decrease over losses of $(0.11) per share from the same period last year.